Formosa Pharmaceuticals and Medvisis Switzerland Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Post-Operative Inflammation and Pain ...Middle East

TAIPEI, Nov. 28, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Medvisis Switzerland AG ("Medvisis") in Switzerland and Liechtenstein, for exclusive rights to the...

Hence then, the article about formosa pharmaceuticals and medvisis switzerland announce licensing agreement for clobetasol propionate ophthalmic suspension for the treatment of post operative inflammation and pain was published today ( Thursday 28/11/2024 - 01:40 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Formosa Pharmaceuticals and Medvisis Switzerland Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Post-Operative Inflammation and Pain )

Also on site :

• Aurora man arrested on suspicion of starting massive Leetsdale Drive fire
• Indiana Toll Road shut down after pileup crash involving around 29 vehicles
• U.S. suspending immigrant visa processing from 75 countries over public assistance